论文部分内容阅读
目的评价云南省第一人民医院胸外科对肺癌手术病人进行临床路径管理的效果,为主管部门控制肺癌医疗费用提供依据。方法调查胸外科2002年1月至2009年9月期间收治的肺癌手术病人的住院信息、住院总费用等,对比肺癌手术病人临床路径管理前后的差异,从而评价临床路径管理对肺癌手术病人管理的意义。结果经过对比分析,研究组的住院总天数显著少于对照组(t=11.768,P<0.01);术前住院日显著少于对照组((t=4.391,P<0.01);住院总费用显著低于对照组((t=2.292,P<0.05);多项分项费用低于对照组(P<0.01或P<0.05)。均具有统计学意义。结论胸外科对肺癌手术病人使用临床路径管理缩短了病人住院总天数、术前的住院日,降低了住院总费用,为来院就诊的肺癌手术病人减轻了负担,对控制肺癌手术病人的医疗费用具有一定的意义。
Objective To evaluate the clinical management of lung cancer patients undergoing thoracic surgery in the First People’s Hospital of Yunnan Province and provide the basis for the competent department to control the medical costs of lung cancer. Methods To investigate the differences of hospitalized patients with lung cancer who underwent surgery between January 2002 and September 2009 and the total cost of hospitalization for lung cancer surgery. significance. Results After comparative analysis, the total hospitalization days in the study group were significantly less than those in the control group (t = 11.768, P <0.01). The days before surgery were significantly less than those in the control group (t = 4.391, P <0.01) Lower than the control group (t = 2.292, P <0.05), and the cost of multiple items was lower than that of the control group (P <0.01 or P <0.05) .Conclusions Thoracic surgery has clinical value Management has shortened the total number of patients hospitalized, preoperative hospital stay, reducing the total cost of hospitalization for hospitalized patients with lung cancer surgery to reduce the burden on the control of patients with lung cancer medical costs have a certain significance.